| 摘要 |
The present invention provides a compound of formula I, in which R1, R2, X and R3 are defined in the Summary of the Invention, or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition. |
| 申请人 |
NOVARTIS AG;BEBERNITZ, GREGORY RAYMOND;CODY, EMMA;DAY, ROBERT FRANCI;PATEL, TAJESH JAYPRAKASH;QIAN, MING;WHITEHEAD, LEWIS;ZABAWA, THOMAS;ZECRI, FREDERIC |
发明人 |
BEBERNITZ, GREGORY RAYMOND;CODY, EMMA;DAY, ROBERT FRANCI;PATEL, TAJESH JAYPRAKASH;QIAN, MING;WHITEHEAD, LEWIS;ZABAWA, THOMAS;ZECRI, FREDERIC |
